Visionix USA launches the new VX 610 fundus camera that empowers practitioners to enhance patient care and easily screen for diabetic retinopathy.
LOMBARD, IL – Visionix USA, a leader in ophthalmic innovation, proudly announces the launch of the VX 610 non-mydriatic automated fundus camera.
This cutting-edge device features auto alignment, auto focus, and auto capture functions, ensuring accurate and consistent imaging. Its innovative cross-polarized light technology provides excellent image clarity without the need for pupil dilation. With a 45-degree field of view and 90-degree mosaic function, the VX 610 offers comprehensive retinal screening capabilities. Designed with a modern touch-screen interface and a compact footprint, the VX 610 seamlessly integrates into any practice, enhancing both diagnostic capabilities and patient experience.
Live demos offered at VEW 2024
The VX 610 will be featured at Vision Expo West booth #F10065 alongside Visionix’s next-generation refraction and screening technologies, Optovue OCTs and OCTAs, and Briot/Weco lens finishing platforms. Attendees will be among the first to experience a live demo of the new VX 610 in the United States. Eyecare professionals who are not attending VEW are invited to request a quote for any Visionix product at: visionix.com/us/quote